Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linlin Luo

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Anesthesiology|August 28, 2025
The GABAergic Parafacial Zone: Integrating Consciousness and Respiratory Control in Sevoflurane AnesthesiaLinlin Luo, Zaixun Qin, Mei Chen, et al.
Analytical Chemistry|September 13, 2013
Fully validated LC-MS/MS assay for the simultaneous quantitation of coadministered therapeutic antibodies in cynomolgus monkey serumHao Jiang, Jianing Zeng, Craig Titsch, et al.
Bioanalysis|April 28, 2018
Surface plasmon resonance as a tool for ligand-binding assay reagent characterization in bioanalysis of biotherapeuticsJia Duo, JoAnne Bruno, Alexander Kozhich, et al.
Journal of Clinical and Translational Science|June 18, 2025
Boosting scientific community values: The impact of social inclusion interventions on biomedical instructorsPaul R Hernandez, Wenyi Du, Cristian Cervantes Aldana, et al.
Clinical Pharmacology and Therapeutics|January 29, 2025
IQ Survey Results on Current Industry Practices-Part 1: Immunogenicity Risk AssessmentChristine Grimaldi, Susan Richards, Daniel Baltrukonis, et al.
Bioanalysis|June 10, 2016
Antibody-drug conjugate bioanalysis using LB-LC-MS/MS hybrid assays: strategies, methodology and correlation to ligand-binding assaysJian Wang, Huidong Gu, Ang Liu, et al.
The AAPS Journal|May 13, 2022
When to Extend Monitoring of Anti-drug Antibodies for High-risk Biotherapeutics in Clinical Trials: an Opinion from the European Immunogenicity PlatformGregor P Lotz, Karin Benstein, Karien Bloem, et al.
Frontiers in Immunology|June 6, 2025
Immunogenicity risk assessment for tailored mitigation and monitoring of biotherapeutics during development: recommendations from the European Immunogenicity PlatformJoanna Grudzinska-Goebel, Karin Benstein, Karien Bloem, et al.
The AAPS Journal|July 8, 2023
Neutralizing Antibody Validation Testing and Reporting HarmonizationHeather Myler, João Pedras-Vasconcelos, Todd Lester, et al.
Bioanalysis|December 5, 2015
2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3--LBA, biomarkers and immunogenicity)Lakshmi Amaravadi, An Song, Heather Myler, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Anesthesiology|August 28, 2025
The GABAergic Parafacial Zone: Integrating Consciousness and Respiratory Control in Sevoflurane AnesthesiaLinlin Luo, Zaixun Qin, Mei Chen, et al.
Analytical Chemistry|September 13, 2013
Fully validated LC-MS/MS assay for the simultaneous quantitation of coadministered therapeutic antibodies in cynomolgus monkey serumHao Jiang, Jianing Zeng, Craig Titsch, et al.
Bioanalysis|April 28, 2018
Surface plasmon resonance as a tool for ligand-binding assay reagent characterization in bioanalysis of biotherapeuticsJia Duo, JoAnne Bruno, Alexander Kozhich, et al.
Journal of Clinical and Translational Science|June 18, 2025
Boosting scientific community values: The impact of social inclusion interventions on biomedical instructorsPaul R Hernandez, Wenyi Du, Cristian Cervantes Aldana, et al.
Clinical Pharmacology and Therapeutics|January 29, 2025
IQ Survey Results on Current Industry Practices-Part 1: Immunogenicity Risk AssessmentChristine Grimaldi, Susan Richards, Daniel Baltrukonis, et al.
Bioanalysis|June 10, 2016
Antibody-drug conjugate bioanalysis using LB-LC-MS/MS hybrid assays: strategies, methodology and correlation to ligand-binding assaysJian Wang, Huidong Gu, Ang Liu, et al.
The AAPS Journal|May 13, 2022
When to Extend Monitoring of Anti-drug Antibodies for High-risk Biotherapeutics in Clinical Trials: an Opinion from the European Immunogenicity PlatformGregor P Lotz, Karin Benstein, Karien Bloem, et al.
Frontiers in Immunology|June 6, 2025
Immunogenicity risk assessment for tailored mitigation and monitoring of biotherapeutics during development: recommendations from the European Immunogenicity PlatformJoanna Grudzinska-Goebel, Karin Benstein, Karien Bloem, et al.
The AAPS Journal|July 8, 2023
Neutralizing Antibody Validation Testing and Reporting HarmonizationHeather Myler, João Pedras-Vasconcelos, Todd Lester, et al.
Bioanalysis|December 5, 2015
2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3--LBA, biomarkers and immunogenicity)Lakshmi Amaravadi, An Song, Heather Myler, et al.
Pageof 8